Suppr超能文献

一种集成纸吸附样品净化和电压辅助液解吸电喷雾电离质谱的微流控平台,用于生物样品分析。

A microfluidic platform integrating paper adsorption-based sample clean-up and voltage-assisted liquid desorption electrospray ionization mass spectrometry for biological sample analysis.

机构信息

Department of Chemistry and Biochemistry, Jackson State University, 1400 Lynch St., Jackson, MS, 39217, USA.

Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, 610041, China.

出版信息

Talanta. 2020 Sep 1;217:121106. doi: 10.1016/j.talanta.2020.121106. Epub 2020 May 1.

Abstract

Clinical application of direct sampling electrospray ionization mass spectrometry (ESI-MS) remains limited due to problems associated with very "dirty" sample matrices. Herein we report on a microfluidic platform that allows direct mass spectrometric analysis of serum samples of microliter sizes. The platform integrates in-line paper adsorption-based sample clean-up and voltage assisted liquid desorption ESI-MS/MS (VAL DESI-MS/MS) to detect multiple targeted compounds of clinical interest. Adenosine monophosphate (AMP), adenosine diphosphate (ADP), and adenosine triphosphate (ATP) were selected as model analytes. Simultaneous quantification of these compounds in human serum samples was demonstrated. For all the three compounds, linear calibration curves were obtained in a concentration range from 0.20 to 20.0 μmol/L with r values ≥ 0.996. Limits of detection were 0.019, 0.015, and 0.011 μmol/L for AMP, ADP, and ATP, respectively. Recovery was found in the range from 96.5% to 103.5% at spiking concentrations of 0.25 and 2.50 μmol/L. The results indicate that the proposed microfluidic mass spectrometric platform is robust and effective. It may have a potential in clinical analysis.

摘要

直接采样电喷雾电离质谱(ESI-MS)的临床应用仍然受到与非常“脏”的样品基质相关的问题的限制。在此,我们报告了一种微流控平台,该平台允许对微升大小的血清样品进行直接质谱分析。该平台集成了在线纸吸附样品净化和电压辅助液体解吸 ESI-MS/MS(VAL DESI-MS/MS),以检测临床相关的多种靶向化合物。选择腺苷一磷酸(AMP)、腺苷二磷酸(ADP)和三磷酸腺苷(ATP)作为模型分析物。在人血清样品中证明了这些化合物的同时定量。对于所有三种化合物,在 0.20 至 20.0 μmol/L 的浓度范围内均获得线性校准曲线,r 值≥0.996。AMP、ADP 和 ATP 的检测限分别为 0.019、0.015 和 0.011 μmol/L。在 0.25 和 2.50 μmol/L 的加标浓度下,回收率在 96.5%至 103.5%之间。结果表明,所提出的微流控质谱平台稳健有效。它可能在临床分析中有应用潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cfb/7275932/be90ad6e1350/nihms-1592320-f0002.jpg

相似文献

5
Advances in coupling microfluidic chips to mass spectrometry.微流控芯片与质谱联用技术的进展。
Mass Spectrom Rev. 2015 Sep-Oct;34(5):535-57. doi: 10.1002/mas.21417. Epub 2014 Jan 7.

本文引用的文献

1
Applications of biosensors in Alzheimer's disease diagnosis.生物传感器在阿尔茨海默病诊断中的应用。
Talanta. 2020 Apr 1;210:120644. doi: 10.1016/j.talanta.2019.120644. Epub 2019 Dec 12.
6
Advances in Clinical Mass Spectrometry.临床质谱分析的进展
Adv Clin Chem. 2017;79:153-198. doi: 10.1016/bs.acc.2016.09.003. Epub 2016 Nov 10.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验